Phase 3, randomized, double-blind, active-comparator (darbepoetin alfa) study of oral roxadustat in CKD patients with anemia on hemodialysis in Japan
Journal of the American Society of Nephrology | Jun 06, 2020
Most read this week
Journal of the American Society of Nephrology | Jun 06, 2020